CLINICAL TRIALS PROFILE FOR GRIFULVIN V

All Clinical Trials for GRIFULVIN V

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00863863 ↗	A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Non-fasting Conditions	Completed	Actavis Inc.	Phase 1	2006-01-01	To compare the rate and extent of absorption of griseofulvin from a test formulation of Griseofulvin 125 mg/5 mL Suspension versus the reference Grifulvin V® 125 mg/5 mL Suspension under fed conditions.
NCT00864071 ↗	A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Fasting Conditions	Completed	Actavis Inc.	Phase 1	2005-11-01	To compare the rate and extent of absorption of griseofulvin from a test formulation of Griseofulvin 125 mg/5 mL Suspension versus the reference Grifulvin V® 125 mg/5 mL Suspension under fasting conditions.

Clinical Trial Conditions for GRIFULVIN V

Condition Name

Condition Name for GRIFULVIN V
Intervention	Trials
Healthy	2

Condition MeSH

Condition MeSH for GRIFULVIN V
Intervention	Trials

Clinical Trial Locations for GRIFULVIN V

Trials by Country

Trials by Country for GRIFULVIN V
Location	Trials
Canada	2

Clinical Trial Progress for GRIFULVIN V

Clinical Trial Phase

Clinical Trial Phase for GRIFULVIN V
Clinical Trial Phase	Trials
Phase 1	2

Clinical Trial Status

Clinical Trial Status for GRIFULVIN V
Clinical Trial Phase	Trials
Completed	2

Clinical Trial Sponsors for GRIFULVIN V

Sponsor Name

Sponsor Name for GRIFULVIN V
Sponsor	Trials
Actavis Inc.	2

Sponsor Type

Sponsor Type for GRIFULVIN V
Sponsor	Trials
Industry	2